Singapore markets open in 1 hour 9 minutes

Repare Therapeutics Inc. (RPTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.30-0.20 (-1.48%)
At close: 04:00PM EDT
13.30 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 566.16M
Enterprise value 290.70M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)65.96
Price/book (mrq)2.51
Enterprise value/revenue 35.27
Enterprise value/EBITDA -2.20

Trading information

Stock price history

Beta (5Y monthly) -0.22
52-week change 3-38.36%
S&P500 52-week change 3-14.01%
52-week high 328.25
52-week low 38.06
50-day moving average 312.41
200-day moving average 313.53

Share statistics

Avg vol (3-month) 3160.39k
Avg vol (10-day) 3114.06k
Shares outstanding 541.94M
Implied shares outstanding 6N/A
Float 816.13M
% held by insiders 15.77%
% held by institutions 190.47%
Shares short (14 Sept 2022) 41.54M
Short ratio (14 Sept 2022) 411.82
Short % of float (14 Sept 2022) 45.85%
Short % of shares outstanding (14 Sept 2022) 43.66%
Shares short (prior month 14 Aug 2022) 41.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,625.53%

Management effectiveness

Return on assets (ttm)-26.64%
Return on equity (ttm)-56.11%

Income statement

Revenue (ttm)8.24M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)143.40%
Gross profit (ttm)-80.25M
EBITDA -132.2M
Net income avi to common (ttm)-132.03M
Diluted EPS (ttm)-3.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)282.09M
Total cash per share (mrq)6.73
Total debt (mrq)6.63M
Total debt/equity (mrq)2.94
Current ratio (mrq)7.35
Book value per share (mrq)5.38

Cash flow statement

Operating cash flow (ttm)-111.71M
Levered free cash flow (ttm)-51.83M